These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3570282)

  • 1. Sulfated glycosaminoglycans in Alzheimer's disease.
    Snow AD; Willmer JP; Kisilevsky R
    Hum Pathol; 1987 May; 18(5):506-10. PubMed ID: 3570282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain.
    Snow AD; Sekiguchi RT; Nochlin D; Kalaria RN; Kimata K
    Am J Pathol; 1994 Feb; 144(2):337-47. PubMed ID: 8311117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfated glycosaminoglycans: a common constituent of all amyloids?
    Snow AD; Willmer J; Kisilevsky R
    Lab Invest; 1987 Jan; 56(1):120-3. PubMed ID: 2432352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfated glycosaminoglycans in amyloid plaques of prion diseases.
    Snow AD; Kisilevsky R; Willmer J; Prusiner SB; DeArmond SJ
    Acta Neuropathol; 1989; 77(4):337-42. PubMed ID: 2523631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of Alzheimer's neurofibrillary tangle in the brains of progressive supranuclear palsy, postencephalitic parkinsonism, Alzheimer's disease, senile dementia and non-demented elderly person.
    Mitsuyama Y; Seyama S
    Folia Psychiatr Neurol Jpn; 1981; 35(2):189-204. PubMed ID: 7286861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and partial characterization of neurofibrillary tangles and amyloid plaque core in Alzheimer's disease: immunohistological studies.
    Gorevic PD; Goñi F; Pons-Estel B; Alvarez F; Peress NS; Frangione B
    J Neuropathol Exp Neurol; 1986 Nov; 45(6):647-64. PubMed ID: 3772397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pick body-like inclusions in the dentate fascia of the hippocampus in Alzheimer's disease.
    Dickson DW; Yen SH; Horoupian DS
    Acta Neuropathol; 1986; 71(1-2):38-45. PubMed ID: 3022536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A4 amyloid protein immunoreactivity is present in Alzheimer's disease neurofibrillary tangles.
    Hyman BT; Van Hoesen GW; Beyreuther K; Masters CL
    Neurosci Lett; 1989 Jul; 101(3):352-5. PubMed ID: 2671814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification in immunolocalization of a new class of proteoglycan (keratan sulfate) to the neuritic plaques of Alzheimer's disease.
    Snow AD; Nochlin D; Sekiguichi R; Carlson SS
    Exp Neurol; 1996 Apr; 138(2):305-17. PubMed ID: 8620929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Mr 60,000 protein phosphorylation is correlated with neocortical neurofibrillary tangles in Alzheimer's disease.
    Saitoh T; Hansen LA; Dobkins KR; Terry RD
    J Neuropathol Exp Neurol; 1988 Jan; 47(1):1-8. PubMed ID: 3334725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid plaques, neurofibrillary tangles and their relevance for the study of Alzheimer's disease.
    Goedert M; Crowther RA
    Neurobiol Aging; 1989; 10(5):405-6; discussion 412-4. PubMed ID: 2682318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Widespread serum amyloid P immunoreactivity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer's disease and other degenerative disorders.
    Kalaria RN; Galloway PG; Perry G
    Neuropathol Appl Neurobiol; 1991 Jun; 17(3):189-201. PubMed ID: 1891063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease.
    Snow AD; Mar H; Nochlin D; Kimata K; Kato M; Suzuki S; Hassell J; Wight TN
    Am J Pathol; 1988 Dec; 133(3):456-63. PubMed ID: 2974240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
    Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
    Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cationic dyes reveal proteoglycans structurally integrated within the characteristic lesions of Alzheimer's disease.
    Snow AD; Lara S; Nochlin D; Wight TN
    Acta Neuropathol; 1989; 78(2):113-23. PubMed ID: 2473592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alz-50, ubiquitin and tau immunoreactivity of neurofibrillary tangles, Pick bodies and Lewy bodies.
    Love S; Saitoh T; Quijada S; Cole GM; Terry RD
    J Neuropathol Exp Neurol; 1988 Jul; 47(4):393-405. PubMed ID: 2838588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Unifying Hypothesis of Alzheimer's Disease: Heparan Sulfate Proteoglycans/Glycosaminoglycans Are Key as First Hypothesized Over 30 Years Ago.
    Snow AD; Cummings JA; Lake T
    Front Aging Neurosci; 2021; 13():710683. PubMed ID: 34671250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau antisera recognize neurofibrillary tangles in a range of neurodegenerative disorders.
    Joachim CL; Morris JH; Kosik KS; Selkoe DJ
    Ann Neurol; 1987 Oct; 22(4):514-20. PubMed ID: 2963585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies to Alzheimer neurofibrillary tangles. 2. Demonstration of a common antigenic determinant between ANT and neurofibrillary degeneration in progressive supranuclear palsy.
    Dickson DW; Kress Y; Crowe A; Yen SH
    Am J Pathol; 1985 Aug; 120(2):292-303. PubMed ID: 2411143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.
    Namba Y; Tomonaga M; Kawasaki H; Otomo E; Ikeda K
    Brain Res; 1991 Feb; 541(1):163-6. PubMed ID: 2029618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.